May 21, 2024 07:02 GMT
Eli Lilly: New Diabetes Drug Approved In China
HEALTHCARE
Eli Lilly LLY (A1/A+): New Anti-Diabetes GLP-1 Approved In China
Eli Lilly China announced that Mufenda® ( Tilpotide Injection) has been approved by the National Medical Products Administration (NMPA).
- The Diabetes / Anti-Obesity arms race continues.
Keep reading...Show less
34 words